We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$447B
AUM Growth
+$39.1B
Cap. Flow
-$684M
Cap. Flow %
-0.15%
Top 10 Hldgs %
27.16%
Holding
15,073
New
1,965
Increased
5,545
Reduced
5,814
Closed
1,500

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$877M
2
BKNG icon
Booking.com
BKNG
+$370M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$329M
4
BA icon
Boeing
BA
+$303M
5
WMT icon
Walmart Inc
WMT
+$291M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$544M
2
MBB icon
iShares MBS ETF
MBB
+$461M
3
NVDA icon
NVIDIA
NVDA
+$452M
4
TMUS icon
T-Mobile US
TMUS
+$426M
5
AAPL icon
Apple
AAPL
+$408M

Sector Composition

Rank Sector Weight
1 Technology 3.15%
2 Healthcare 3.06%
3 Financials 2.35%
4 Consumer Discretionary 2.28%
5 Industrials 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLRE icon
12451
CALL
Greenlight Captial
GLRE
$514M
$137K ﹤0.01%
15,000
-18,700
-55% -$171K
MYPSW
12452
DELISTED
PLAYSTUDIOS Inc Warrant
MYPSW
$137K ﹤0.01%
74,283
+3,746
+5% +$6.57K
QTTB icon
12453
CALL
Q32 Bio
QTTB
$451M
$137K ﹤0.01%
1,044
-95
-8% -$11.9K
GMDA
12454
CALL
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$137K ﹤0.01%
21,400
-15,800
-42% -$109K
SEAC
12455
CALL
DELISTED
Seachange International Inc
SEAC
$137K ﹤0.01%
5,300
+3,075
+138% +$72.5K
HUGS.WS
12456
DELISTED
USHG Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
HUGS.WS
$137K ﹤0.01%
+133,421
New +$129K
RCHG
12457
DELISTED
Recharge Acquisition Corp. Class A Common Stock
RCHG
$137K ﹤0.01%
13,968
+728
+5% +$7.17K
AWRE icon
12458
PUT
Aware
AWRE
$26.4M
$136K ﹤0.01%
36,700
+200
+0.5% +$736
HOOK
12459
CALL
DELISTED
HOOKIPA Pharma
HOOK
$136K ﹤0.01%
1,480
-1,740
-54% -$232K
LSAK icon
12460
Lesaka Technologies
LSAK
$407M
$136K ﹤0.01%
28,883
-42,587
-60% -$222K
LSTA icon
12461
PUT
Lisata Therapeutics
LSTA
$9.82M
$136K ﹤0.01%
5,620
+473
+9% +$11.2K
SJT
12462
PUT
San Juan Basin Royalty Trust
SJT
$131M
$136K ﹤0.01%
26,400
+11,600
+78% +$58.2K
QCLS
12463
Q/C Technologies Inc
QCLS
$21.8M
$136K ﹤0.01%
7
+3
+75% +$44.1K
APTO
12464
CALL
DELISTED
Aptose Biosciences, Inc.
APTO
$136K ﹤0.01%
91
-145
-61% -$316K
MACC.WS
12465
DELISTED
Mission Advancement Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
MACC.WS
$136K ﹤0.01%
+167,539
New +$110K
BSN.U
12466
DELISTED
Broadstone Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of on
BSN.U
$136K ﹤0.01%
12,955
+376
+3% +$3.87K
SAII
12467
PUT
DELISTED
Software Acquisition Group Inc. II Class A Common Stock
SAII
$136K ﹤0.01%
+13,700
New +$137K
PLM
12468
DELISTED
PolyMet Mining Corp.
PLM
$136K ﹤0.01%
37,553
+24,708
+192% +$77.7K
ADTX
12469
CALL
DELISTED
ADITXT INC
ADTX
0
DHF
12470
BNY Mellon High Yield Strategies Fund
DHF
$174M
$135K ﹤0.01%
+36,998
New +$118K
GNFT
12471
DELISTED
Genfit
GNFT
$135K ﹤0.01%
34,954
+267
+0.8% +$1.12K
INVA icon
12472
CALL
Innoviva
INVA
$1.53B
$135K ﹤0.01%
10,100
-4,500
-31% -$56.3K
IZEA icon
12473
IZEA Worldwide
IZEA
$53.8M
$135K ﹤0.01%
13,196
-16,948
-56% -$222K
QUIK icon
12474
CALL
QuickLogic
QUIK
$234M
$135K ﹤0.01%
18,700
-24,300
-57% -$159K
AMYT
12475
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
$135K ﹤0.01%
+11,130
New +$138K

Similar funds

Citadel Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Citadel Advisors held 15,073 positions worth $447B, up 9.6% from $408B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Citadel Advisors's Q2 2021 filing shows 1,965 new, 5,545 increased, 5,814 reduced and 1,500 closed positions. Its largest new stake was Coinbase: 1,010,057 shares worth $256M. The largest sale was Microsoft, an estimated $544M.

By sector, the portfolio is most concentrated in Technology at 3.2% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

  • Citadel Advisors's largest Q2 2021 buy was Coinbase: 1,010,057 shares worth $256M.
  • Citadel Advisors added most to AT&T in Q2 2021, an estimated $877M increase.
  • Citadel Advisors's biggest Q2 2021 reduction was Microsoft, cutting an estimated $544M.
  • Citadel Advisors fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $197M.
  • Citadel Advisors's ten largest holdings make up 27% of its $447B portfolio in Q2 2021.
  • Citadel Advisors opened 1,965 new positions and closed 1,500 in Q2 2021.
  • Citadel Advisors's portfolio value rose 9.6% quarter-over-quarter to $447B.

Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.